Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · IEX Real-Time Price · USD
0.735
+0.003 (0.42%)
At close: Jul 2, 2024, 4:00 PM
0.750
+0.015 (2.01%)
After-hours: Jul 2, 2024, 5:54 PM EDT
Bolt Biotherapeutics Revenue
Bolt Biotherapeutics had revenue of $11.32M in the twelve months ending March 31, 2024, with 67.96% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.27M with 188.83% year-over-year growth. In the year 2023, Bolt Biotherapeutics had annual revenue of $7.88M with 37.48% growth.
Revenue (ttm)
$11.32M
Revenue Growth
+67.96%
P/S Ratio
2.47
Revenue / Employee
$113,240
Employees
100
Market Cap
28.02M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.88M | 2.15M | 37.48% |
Dec 31, 2022 | 5.73M | 4.47M | 354.68% |
Dec 31, 2021 | 1.26M | 1.03M | 445.45% |
Dec 31, 2020 | 231.00K | 16.00K | 7.44% |
Dec 31, 2019 | 215.00K | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBOLT News
- 9 hours ago - Pomerantz Law Firm Announces the Filing of a Class Action Against Bolt Biotherapeutics, Inc. and Certain Officers - BOLT - PRNewsWire
- 6 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeutics, Inc. - BOLT - Accesswire
- 8 days ago - Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 15 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bolt Biotherapeutics, Inc. - BOLT - Accesswire
- 27 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeutics, Inc. - BOLT - GlobeNewsWire
- 4 weeks ago - Bolt Biotherapeutics, Inc. (BOLT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - Accesswire
- 4 weeks ago - Bolt Biotherapeutics, Inc. (BOLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - Accesswire
- 6 weeks ago - ATTENTION BOLT SHAREHOLDERS: Investors who Lost Money on Bolt Biotherapeutics, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - Accesswire